| Biomarker ID | 1166 |
| PMID | 23840433 |
| Year | 2013 |
| Biomarker | Cyclin-dependent kinase 5, regulatory subunit 1 (CDK5R1) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Lissencephaly gene (LIS1) in neuronal migration and development, Reelin signaling pathway, MAPK/TRK pathway, Ck1/Cdk5 regulation by type 1 glutamate receptors, CRMPs in Sema3A signaling |
| Experiment | Cancerous Vs non cancerous conditions |
| Type of Biomarker | Diagnostic |
| Cohort | 50 cancerous and 44 non cancerous prostate specimens were included for the study |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.719 (95% CI: 0.6.0-0.831) |
| Accuracy | NA |
| Level Of Significance | p<0.01 |
| Method Used | RT - qPCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on human patient cohort |
| Technical Name | NA |